Literature DB >> 20218016

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

G Lam1, W L Chiou.   

Abstract

Using an equation for the calculation of plasma profiles of drug based on the zero-order input and Michaelis-Menten kinetic output in a one-compartment open model system, the times required to reach various degrees of several steady-state plasma concentrations of phenytoin are calculated. The effect of the apparent volume of distribution (due to intersubject variation or change in protein and/or tissue binding, etc.) on the time required to reach various fractions of steady-state plasma concentrations is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 20218016     DOI: 10.1007/bf01059740

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  15 in total

1.  Elimination of alcohol from human blood.

Authors:  J G Wagner; P K Wilkinson; A J Sedman; D R Kay; D J Weidler
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

2.  Dose-dependent kinetics of theophylline disposition in asthmatic children.

Authors:  M Weinberger; E Ginchansky
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

3.  A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments.

Authors:  A Richens
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

4.  Pharmacokinetic study of a patient with diphenylhydantoin toxicity.

Authors:  A J Atkinson; J M Shaw
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Salicylate accumulation kinetics in man.

Authors:  G Levy; T Tsuchiya
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

6.  Pharmacokinetics of alcohol following single low doses to fasted and nonfasted subjects.

Authors:  P G Welling; L L Lyons; R Elliott; G L Amidon
Journal:  J Clin Pharmacol       Date:  1977-04       Impact factor: 3.126

7.  The clinical pharmacokinetics of phenytoin.

Authors:  E Martin; T N Tozer; L B Sheiner; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

8.  Phenytoin: pharmacokinetics and bioavailability.

Authors:  R Gugler; C V Manion; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

9.  Diphenylhydantoin elimination kinetics in overdosed children.

Authors:  L K Garrettson; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

10.  Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.

Authors:  N Gerber; R Lynn; J Oates
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

View more
  3 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 2.  Stable isotopes in clinical pharmacokinetic investigations. Advantages and disadvantages.

Authors:  T R Browne
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

3.  Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-11       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.